About this trial
A prospective randomized controlled study evaluating the impact of various treatment modalities for cesarean scar pregnancy on treatment outcomes and pregnancy outcomes
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Women over 18 years old with a history of cesarean section
Ultrasound diagnosis of cesarean scar pregnancy
No severe internal or external diseases, such as liver disease, kidney disease, cardiovascular disease, cerebrovascular disease, etc., and able to tolerate surgery
Disqualifiers
Women under the age of 18
CSP patients who have received treatment in other hospitals
Trial population
A prospective randomized controlled study evaluating the impact of various treatment modalities for cesarean scar pregnancy on treatment outcomes and pregnancy outcomes. The excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach. Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.
Trial design
Case-control
Prospective
Treatments tested in this trial
different surgical treatment
Other interventionThe excisional surgeries were conducted via excision of the cesarean scar pregnancy and closure of the uterine incision through a transvaginal approach or hysteroscopy-assisted laparoscopic approach. Conservative surgeries refer to the removal of intrauterine pregnancy tissues through ultrasound-guided vacuum aspiration or hysteroscopic surgery.
Treatment groups
Trial outcomes
Primary outcomes
successful surgical treatment
successful treatment rate after surgery
Secondary outcomes
complication
severe complication rate after surgery
Other outcomes
subsequent pregnancy rate
subsequent pregnancy rate after surgery
CSP recurrence rate
CSP recurrence rate after surgery
pregnancy interval
pregnancy interval after surgery
Sponsors and contacts
Click on the lead sponsor to view all of their trials.